# Finward Bancorp: overview

FNWD · Nasdaq · CIK 919864 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fnwd.md) · [Financials](/companies/fnwd/financials.md) · [Filings](/companies/fnwd/filings.md) · [Insiders](/companies/fnwd/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [0.14](/filings/0001628280-25-051584.md) | not reported | [0.11](/filings/0001628280-26-034588.md) | [0.50](/filings/0001628280-26-056715.md) | [0.81](/filings/0001628280-25-051584.md) | not reported | [0.52](/filings/0001628280-26-034588.md) | [0.48](/filings/0001628280-26-056715.md) |
| Free cash flow | $m | [(4.2) d](/filings/0001628280-25-051584.md) | [10.6 d](/filings/0001628280-26-021073.md) | [(4.0)](/filings/0001628280-26-034588.md) | [4.5 d](/filings/0001628280-26-056715.md) | [1.0 d](/filings/0001628280-25-051584.md) | [7.5 d](/filings/0001628280-26-021073.md) | [3.5](/filings/0001628280-26-034588.md) | [4.5 d](/filings/0001628280-26-056715.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [4.30](/filings/0001437749-23-008638.md) | [3.60](/filings/0001437749-24-009816.md) | [1.96](/filings/0001437749-25-010182.md) | [2.84](/filings/0001628280-26-021073.md) | [1.88](/filings/0001628280-26-021073.md) |
| Free cash flow | $m | [13.9](/filings/0001437749-23-008638.md) | [14.7](/filings/0001437749-24-009816.md) | [23.1](/filings/0001437749-25-010182.md) | [6.7](/filings/0001628280-26-021073.md) | [9.0](/filings/0001628280-26-021073.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fnwd/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $15.1m | 417,190 |  | Added +3,455 |
| [PL Capital Advisors, LLC](/funds/1569147.md) | 2026-06-30 | $14.6m | 395,716 |  | Unchanged |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $6.0m | 162,149 |  | Reduced −153 |
| [Finward Bancorp](/funds/919864.md) | 2026-06-30 | $4.8m | 131,360 |  | Reduced −200 |
| [ENDEAVOUR CAPITAL ADVISORS INC](/funds/1218749.md) | 2026-06-30 | $3.7m | 99,543 |  | Unchanged |
| [Elizabeth Park Capital Advisors, Ltd.](/funds/1600583.md) | 2026-06-30 | $2.1m | 57,622 |  | New +57,622 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $2.0m | 53,656 |  | Reduced −1,554 |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $1.7m | 45,300 |  | Added +200 |
| [HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC](/funds/1164833.md) | 2026-06-30 | $1.7m | 44,940 |  | Added +300 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $1.5m | 41,970 |  | Reduced −38,680 |

## Recent filings

[All 1,127 filings](/companies/fnwd/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 16:10 ET | [8-K](/filings/0001628280-26-067582.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-067582 |
| 2026-09-04 | 16:05 ET | [8-K](/filings/0001628280-26-060718.md) | 8.01 Other events | 0001628280-26-060718 |
| 2026-08-13 | 16:10 ET | [10-Q](/filings/0001628280-26-056715.md) | Quarterly report, period 2026-06-30 | 0001628280-26-056715 |
| 2026-07-28 | 16:50 ET | [8-K](/filings/0001628280-26-050219.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-050219 |
| 2026-07-21 | 16:30 ET | [8-K](/filings/0001193125-26-310388.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-310388 |
| 2026-07-06 | 16:45 ET | [8-K](/filings/0001628280-26-047308.md) | 8.01 Other events | 0001628280-26-047308 |
| 2026-06-03 | 16:04 ET | [8-K](/filings/0001628280-26-040209.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-040209 |
| 2026-05-28 | 16:30 ET | [8-K/A](/filings/0001628280-26-038851.md) | 5.07 Shareholder vote results | 0001628280-26-038851 |
| 2026-05-26 | 16:06 ET | [8-K](/filings/0001628280-26-038070.md) | 5.07 Shareholder vote results | 0001628280-26-038070 |
| 2026-05-13 | 16:05 ET | [10-Q](/filings/0001628280-26-034588.md) | Quarterly report, period 2026-03-31 | 0001628280-26-034588 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-021073.md), filed Mar 25, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 919864
- Tickers: FNWD
- Exchange: Nasdaq
- SIC code: 6035 Savings Institution, Federally Chartered
- State of incorporation: IN
- Filer category: Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 16:19 ET. No prices; not investment advice.
